LGVNLongeveron Inc.

Nasdaq longeveron.com


$ 3.17 $ 0.50 (18.59 %)    

Friday, 14-Jun-2024 15:59:56 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 3.19
$ 3.60
$ 0.00 x 0
$ 0.00 x 0
$ 2.84 - $ 4.10
$ 0.77 - $ 40.00
98,033,691
na
20.25M
$ 0.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-longeveron-stock

Longeveron shares are trading higher Thursday, and the stock is up more than 200% this week. Here's a look at what's go...

 longeveron-shares-resume-trade
Longeveron Shares Resume Trade
06/13/2024 14:13:05

Core News & Articles
Market-Moving News for June 13th
06/13/2024 12:28:13

TSLA: 7% | Tesla Bull Gary Black Sees Elon Musk's $56B Pay Package Pass 'Easily' At Shareholder Meeting; Expects St...

 why-are-longeveron-shares-trading-higher-wednesday

Longeveron Inc. (NASDAQ: LGVN) shares are moving higher on Wednesday afternoon following the circulation of a Zacks Small Cap R...

 watching-longeveron-zacks-small-cap-research-issues-1510-price-valuation-says-longeveron-is-focusing-on-using-its-primary-treatment-lomecel-b-to-fight-a-rare-pediatric-heart-birth-defect-that-devastates-families-announced-the-completion-of-an-encouraging-meeting-with-investigators-involved-in-the-ongoing-trial-of-lomecel-b-for-the-treatment-of-hlhs

https://scr.zacks.com/files/News/2024/Zacks_SCR_Research_06122024_LGVN_Sorensen.pdf

 longeveron-completes-successful-investigator-meeting-for-on-going-phase-2b-clinical-trial-evaluating-lomecel-b-as-potential-treatment-for-hlhs-rare-pediatric-cardiac-disease

Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ ...

 hc-wainwright--co-reiterates-buy-on-longeveron-maintains-12-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Longeveron (NASDAQ:LGVN) with a Buy and maintains $12 price ta...

 longeveron-q1-eps-161-beats-200-estimate-sales-54800k-beat-10000k-estimate

Longeveron (NASDAQ:LGVN) reported quarterly losses of $(1.61) per share which beat the analyst consensus estimate of $(2.00) by...